DS
VXRT

David Shaw’s Vaxart VXRT Stock Holding History

David Shaw’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-174,606
Closed -$227K – 4879
2024
Q1 		$227K Buy
174,606
+66,838
+62% +$70K ﹤0.01% 3875
2023
Q4 		$61.7K Buy
107,768
+96,975
+898% +$67K ﹤0.01% 4012
2023
Q3 		$8.14K Sell
10,793
-248,723
-96% -$189K ﹤0.01% 4085
2023
Q2 		$189K Sell
259,516
-721,867
-74% -$671K ﹤0.01% 3752
2023
Q1 		$743K Sell
981,383
-245,224
-20% -$228K ﹤0.01% 3350
2022
Q4 		$1.18M Buy
1,226,607
+656,650
+115% +$928K ﹤0.01% 3324
2022
Q3 		$1.24M Sell
569,957
-470,429
-45% -$1.62M ﹤0.01% 3428
2022
Q2 		$3.64M Sell
1,040,386
-552,255
-35% -$2.06M ﹤0.01% 2520
2022
Q1 		$8.03M Sell
1,592,641
-534,283
-25% -$2.71M 0.01% 1813
2021
Q4 		$13.3M Buy
2,126,924
+993,652
+88% +$6.78M 0.01% 1408
2021
Q3 		$9.01M Buy
1,133,272
+1,119,856
+8,347% +$9.22M 0.01% 1591
2021
Q2 		$100K Buy
+13,416
New +$93.7K ﹤0.01% 4552

Other funds holding VXRT

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's VXRT Position: Q2 2024 in Review

David Shaw sold out of Vaxart (VXRT) in Q2 2024, closing a stake of 174,606 shares — an estimated $227K sold.

David Shaw first reported a position in VXRT in Q2 2021 and held it in 12 quarters. The position peaked at $13.3M in Q4 2021. 100 funds tracked by Wall St. Rank hold VXRT as of Q2 2024.

  • David Shaw reported no remaining Vaxart position as of Q2 2024 after selling out during the quarter.
  • David Shaw sold 174,606 Vaxart shares in Q2 2024, an estimated $227K.
  • David Shaw first reported a position in Vaxart in Q2 2021 and held it in 12 quarters.
  • David Shaw's Vaxart position peaked at $13.3M in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.